Get informed when a big investor buys or sells
+ Follow-0.01
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
The latest PEG ratio for TRRI is -0.01. That is above the sector sector average of -0.46. Investors often review this figure alongside Alzex Neuropharma's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, TRRI currently prints -0.01 for PEG ratio, while the sector average sits near -0.46. That is roughly 98.6% above the sector mean. Large gaps often invite a closer look at Alzex Neuropharma's growth, margins, and balance sheet.
A PEG ratio of -0.01 for Alzex Neuropharma is not 'good' or 'bad' on its own. Compare it with the peer average (-0.46) and with TRRI's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting TRRI's PEG ratio (-0.01), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.